Cocrystal Pharma Inc./$COCP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
Ticker
$COCP
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
11
ISIN
US19188J4094
Website
COCP Metrics
BasicAdvanced
$17M
-
-$1.56
2.12
-
Price and volume
Market cap
$17M
Beta
2.12
52-week high
$1.87
52-week low
$1.12
Average daily volume
23K
Financial strength
Current ratio
4.571
Quick ratio
4.332
Long term debt to equity
19.496
Total debt to equity
23.727
Management effectiveness
Return on assets (TTM)
-53.96%
Return on equity (TTM)
-106.05%
Valuation
Price to book
2.27
Price to tangible book (TTM)
2.27
Price to free cash flow (TTM)
-1.111
Growth
Earnings per share change (TTM)
-5.53%
3-year earnings per share growth (CAGR)
-7.65%
COCP News
AllArticlesVideos
Cocrystal Pharma's Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference
GlobeNewsWire·4 days ago
Cocrystal Pharma's Investigational Drug Candidate CC-42344 Demonstrates Strong Antiviral Potency Against the 2024 Highly Pathogenic H5N1 Avian Influenza Strain
GlobeNewsWire·2 weeks ago
Cocrystal Pharma to Participate in Noble Capital Markets' 2025 Emerging Growth Virtual Equity Conference
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cocrystal Pharma Inc. stock?
Cocrystal Pharma Inc. (COCP) has a market cap of $17M as of June 09, 2025.
What is the P/E ratio for Cocrystal Pharma Inc. stock?
The price to earnings (P/E) ratio for Cocrystal Pharma Inc. (COCP) stock is 0 as of June 09, 2025.
Does Cocrystal Pharma Inc. stock pay dividends?
No, Cocrystal Pharma Inc. (COCP) stock does not pay dividends to its shareholders as of June 09, 2025.
When is the next Cocrystal Pharma Inc. dividend payment date?
Cocrystal Pharma Inc. (COCP) stock does not pay dividends to its shareholders.
What is the beta indicator for Cocrystal Pharma Inc.?
Cocrystal Pharma Inc. (COCP) has a beta rating of 2.12. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.